• Accueil >
  • Publications >
  • Uncommon EGFR mutations in lung adenocarcinoma: features and response to tyrosine kinase inhibitors

Uncommon EGFR mutations in lung adenocarcinoma: features and response to tyrosine kinase inhibitors

1 sept. 2020Journal of Thoracic Disease

DOI : 10.21037/jtd-19-3790

Auteurs

Aurélien Brindel, Wajd Althakfi, Marc Barritault, Emmanuel Watkin, Jean-Michel Maury, Pierre-Paul Bringuier, Nicolas Girard, Marie Brevet